Inogen Inc Stock Performance
| INGN Stock | USD 8.96 0.31 3.34% |
The company retains a Market Volatility (i.e., Beta) of 1.32, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Inogen will likely underperform. At this point, Inogen Inc has a negative expected return of -0.24%. Please make sure to check out Inogen's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Inogen Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Inogen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (3.34) | Five Day Return (6.18) | Year To Date Return 58.02 | Ten Year Return (64.07) | All Time Return (40.86) |
1 | Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC | 10/08/2024 |
2 | Inogen, Inc. A Bear Case Theory | 11/07/2024 |
3 | Inogen, Inc. Short Interest Down 11.4 percent in October | 11/19/2024 |
4 | Inogen May Find a Bottom Soon, Heres Why You Should Buy the Stock Now | 11/25/2024 |
5 | Disposition of 12942 shares by Ramade Gregoire of Inogen at 9.71 subject to Rule 16b-3 | 11/29/2024 |
6 | Inogen Alliance Releases 2023 ESG Report | 12/02/2024 |
7 | The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen | 12/12/2024 |
| Begin Period Cash Flow | 187 M | |
| Free Cash Flow | -30.2 M |
Inogen |
Inogen Relative Risk vs. Return Landscape
If you would invest 1,084 in Inogen Inc on September 17, 2024 and sell it today you would lose (188.00) from holding Inogen Inc or give up 17.34% of portfolio value over 90 days. Inogen Inc is currently does not generate positive expected returns and assumes 3.1841% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than Inogen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Inogen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inogen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Inogen Inc, and traders can use it to determine the average amount a Inogen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0769
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | INGN |
Estimated Market Risk
| 3.18 actual daily | 28 72% of assets are more volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Inogen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inogen by adding Inogen to a well-diversified portfolio.
Inogen Fundamentals Growth
Inogen Stock prices reflect investors' perceptions of the future prospects and financial health of Inogen, and Inogen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Inogen Stock performance.
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0966 | ||||
| Profit Margin | (0.16) % | ||||
| Operating Margin | (0.08) % | ||||
| Current Valuation | 112.9 M | ||||
| Shares Outstanding | 23.82 M | ||||
| Price To Earning | 61.63 X | ||||
| Price To Book | 1.15 X | ||||
| Price To Sales | 0.64 X | ||||
| Revenue | 315.66 M | ||||
| Gross Profit | 153.53 M | ||||
| EBITDA | (58.34 M) | ||||
| Net Income | (102.45 M) | ||||
| Cash And Equivalents | 223.62 M | ||||
| Cash Per Share | 9.78 X | ||||
| Total Debt | 21.92 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 5.32 X | ||||
| Book Value Per Share | 7.78 X | ||||
| Cash Flow From Operations | (3.23 M) | ||||
| Earnings Per Share | (2.25) X | ||||
| Market Capitalization | 213.41 M | ||||
| Total Asset | 326.19 M | ||||
| Retained Earnings | (116.95 M) | ||||
| Working Capital | 134.57 M | ||||
| Current Asset | 114.84 M | ||||
| Current Liabilities | 22.01 M | ||||
About Inogen Performance
By examining Inogen's fundamental ratios, stakeholders can obtain critical insights into Inogen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Inogen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 42.19 | 41.21 | |
| Return On Tangible Assets | (0.36) | (0.35) | |
| Return On Capital Employed | (0.43) | (0.41) | |
| Return On Assets | (0.31) | (0.30) | |
| Return On Equity | (0.50) | (0.48) |
Things to note about Inogen Inc performance evaluation
Checking the ongoing alerts about Inogen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Inogen Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Inogen Inc generated a negative expected return over the last 90 days | |
| Inogen Inc has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 315.66 M. Net Loss for the year was (102.45 M) with profit before overhead, payroll, taxes, and interest of 153.53 M. | |
| Inogen Inc currently holds about 223.62 M in cash with (3.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Inogen Inc has a strong financial position based on the latest SEC filings | |
| Over 90.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen |
- Analyzing Inogen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Inogen's stock is overvalued or undervalued compared to its peers.
- Examining Inogen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Inogen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Inogen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Inogen's stock. These opinions can provide insight into Inogen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.873 | Earnings Share (2.25) | Revenue Per Share 14.095 | Quarterly Revenue Growth 0.058 | Return On Assets (0.1) |
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.